Isidore S Edelman

Title: Isidore S. Edelman: Innovator in Kaposi's Sarcoma Research

Introduction

Isidore S. Edelman is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the study of Kaposi's Sarcoma. With a total of 12 patents, his work has had a profound impact on the understanding and treatment of this disease.

Latest Patents

Edelman's latest patents focus on unique associated Kaposi's Sarcoma virus sequences and their uses. One of his notable inventions provides an isolated nucleic acid molecule that encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. Additionally, he has developed an isolated polypeptide molecule of KSHV and an antibody specific to this polypeptide. His inventions also include antisense and triplex oligonucleotide molecules. Furthermore, he has created a vaccine for Kaposi's Sarcoma (KS) and methods for vaccination, prophylaxis, diagnosis, and treatment of subjects with KS. His work also encompasses detecting the expression of a DNA virus associated with Kaposi's Sarcoma in cells.

Career Highlights

Edelman is affiliated with Columbia University, where he continues to advance his research and innovations. His career has been marked by a commitment to understanding the complexities of viral infections and their implications for human health.

Collaborations

Throughout his career, Edelman has collaborated with notable researchers, including Yuan Chang and Roy A. Bohenzky. These partnerships have further enriched his contributions to the field.

Conclusion

Isidore S. Edelman's innovative work in the realm of Kaposi's Sarcoma research exemplifies the vital role of inventors in advancing medical science. His patents and collaborations continue to pave the way for new treatments and understanding of this disease.